Tests heat-based ablation for small, low-risk thyroid cancer
Tests radiofrequency ablation, a heat treatment, in adults with small thyroid cancer.
Key facts
- Who runs it
- University Health Network, Toronto
- Where
- Toronto, CanadaSee the site
- Trial code
- Registry title
- The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 20 Apr 2023
- Planned end
- 31 Dec 2025
- Type of study
- Interventional
- Treatments tested
- Radiofrequency ablation
- Record updated
- 16 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a small thyroid nodule, 2 cm (0.8 in) or less, that was graded Bethesda 5/6. It tests treating the nodule with radiofrequency ablation.
- Age
- 18 to 100 years
- Sex
- All sexes can join.
- Disease stage
- A thyroid nodule of 2 cm or less in size, graded Bethesda 5/6.
- Earlier treatment
- People previously treated for thyroid cancer cannot join.
Main reasons for not taking part
- Under 18 years old
- Pregnant women
- Any concern for invasive or metastatic thyroid cancer
- Previously treated for thyroid cancer
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients with:
- Nodule less than or equal to 2cm in size; Specifically: Bethesda 5/6
- Their age is ≥18 years and ≤100 years
- Able to provide written consent
- Able to attend required follow-ups as per the protocol
Who cannot take part
- Previously treated for thyroid cancer
- Any concern for invasive or metastatic thyroid cancer
- Patients <18 years old
- Pregnant women
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in Canada
- University Health NetworkToronto, CanadaContact: Ilhaan AbdulleTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is:
Read full original descriptionShow less
• What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)?
Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three follow-up appointments at 4 weeks, 6 months, and 12 months post-procedure as per standard of care.
The group in the trial
- InterventionTreatment being tested
Participants receive RFA intervention for thyroid nodule.
Treatment: Radiofrequency ablation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Thermo-Ablation With Radiofrequency Medical Technologies to Treat Thyroid Cancers
- Plain-language title
- Tests heat-based ablation for small, low-risk thyroid cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06929650, who can take part
- Record updated
- 16 April 2025